Simplex Trading’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
Other funds holding IMNM
RG
VCM
DCM
ES
Simplex Trading's IMNM Position: Q1 2026 in Review
Simplex Trading sold out of Immunome (IMNM) in Q1 2026, closing a stake of 23,401 shares — an estimated $521K sold.
Simplex Trading first reported a position in IMNM in Q2 2021 and held it in 17 quarters. The position peaked at $722K in Q3 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.
- Simplex Trading reported no remaining Immunome position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 23,401 Immunome shares in Q1 2026, an estimated $521K.
- Simplex Trading first reported a position in Immunome in Q2 2021 and held it in 17 quarters.
- Simplex Trading's Immunome position peaked at $722K in Q3 2025.
- 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.